BOSTAL LLC

A New Jersey based pharmaceutical company founded in July 2004


18Mayfield_Bostal

ABOUT US

Bostal LLC (formerly AustarPharma, “Bostal US”), a pharmaceutical company specializing in drug delivery technologies. Founded in 2004 by Dr. Ron Liu in Edison, NJ, USA, the company is supported by a team of highly experienced professionals. Our management team has an average of over 25 years of experience in the pharmaceutical industry.

Bostal Drug Delivery (“Bostal China”) founded by Dr. Ron Liu in Guangzhou, China, 2013. 

Read More

OUR GOAL

Our goal and commitment is to bring quality products and reliable delivery to our valued customers.

Read More
tree

WHAT MAKES US SPECIAL

platform technology based

Bostal LLC is a pharmaceutical company driven by platform technology, focused on enhancing the performance of established and successful pharmaceutical products already in or entering the market.

long-acting injectable (LAI) platform technologies

Our long-acting injectable (LAI) platform technologies, including Zpheres® (microspheres), Geleepot® (in-situ gel), and nanosystems, are transforming pharmaceutical innovation by redefining drug delivery to enhance patient outcomes and unlock new treatment possibilities.

laboratories and commercial manufacturing facilities

The Company is equipped with state-of-the-art laboratories and commercial manufacturing facilities, having passed multiple GMP inspections by the FDA, EU, and other regulatory authorities. 

OUR SERVICES

Bostal LLC has a highly experienced R&D team with deep scientific expertise and hands-on knowledge across multiple drug delivery technology platforms. Our extensive pharmaceutical processing capabilities enable us to support various development and manufacturing needs, whether for new chemical entities or well-established drug molecules.

Product Capability

505(b)(2) Product Introduction

new6
SEMAGLUTIDE LAI

new4
Brexpiprazole LAI 1M

new5
Development Pipeline

WHY CHOOSE US

Our deep expertise in intellectual property, technology assessment, and FDA regulations, combined with our experience in the U.S. generic pharmaceutical market, allows us to offer comprehensive, turn-key solutions for international investors seeking entry into the U.S. generic market. From project evaluation and product development to bioequivalence assessment, ANDA submission, commercial manufacturing, and sales & marketing post-ANDA approval, we provide end-to-end support for a successful market launch.


Operational Excellence

Optimizing processes to deliver high quality, efficient, and compliant pharmaceutical solutions.

Continuous Growth

Committed to innovation, quality, and continuous progress in delivering advanced pharmaceutical solutions.

Team of experts

We focused on advancing pharmaceutical solutions through innovative approaches and precise execution.

1+
Total Employees
1%
EMPLOYEES wITH MASTER oR Ph.D. dEGREES
1+
R&D Employess
1+
Years of experience